http://www.dictall.com/indu/317/31681743770.htm WebbDepartment for Disinfection and Infection Control, Chinese PLA Center for Disease Control and Prevention ... bafilomycin A1 was able to significantly down-regulate the release of inflammatory factors in BEAS-2B cells upon A. fumigatus conidia, while rapamycin could reverse the effect of JNK inhibitor on IL-27 and TNF-α release.
インターフェロン製剤(肝炎などの治療薬) - 解説(効能効果・ …
Webb对于在同一试验中不同的给药方案,该试验的主要研究者之一McHutchison在2005年1月7日接受路透社采访时曾经如此评论:“利巴韦林对于病毒抑制非常重要,该试验设计使聚乙二醇干扰素α-2b(12KD)治疗组可能接受更大剂量的利巴韦林,进而将直接影响试验结果,导致试验结果向有利于聚乙二醇干扰素α-2b(12KD)的 ... Webb47 Female INFα2b Chronic viral hepatitis 3 MIU/three times weekly Interrupted after 6 months During therapy Interruption of IFN therapy and prednisone 1mg/kg/day Limited form of systemic sclerosis Solans et al. [3] 52 Female INFα2a Chronic myelogenous leukaemia 6 MIU/daily 25 months During therapy Loop diuretics, cyclophos-phamide … does the null hypothesis always equal
Peginterferon alfa-2b - Wikipedia
http://www.a-hospital.com/w/%E8%81%9A%E4%B9%99%E4%BA%8C%E9%86%87%E5%B9%B2%E6%89%B0%E7%B4%A0%CE%B1-2b WebbIn addition r-IFN-α are associated with psychiatric, haematological and renal adverse effects. Therapy with IFN-α 2a or 2b may induce development of auto-antibodies. A variety of immune-mediated disorders such as thyroid disease, rheumatoid arthritis, systemic lupus erythematosus, neuropathies and vasculitis have been observed with r-IFN-α. Webb12 jan. 2009 · The 5-year OS rates of 46% and 52%, previously reported for the 1-year INF-α-2b treatment arm in the E1684 and E1690 studies, respectively, are close to the observed 5-year OS rates (56% and 54% for arms A and B) in the current study, whereas the 5-year RFS rate reported in the E1684 study (37%) is similar to the 5-year RFS … does the nuface mini vibrate